Page last updated: 2024-10-22

aristolochic acid i and Hypokalemic Periodic Paralysis

aristolochic acid i has been researched along with Hypokalemic Periodic Paralysis in 1 studies

aristolochic acid I: phospholipase A inhibitor
aristolochic acid A : An aristolochic acid that is phenanthrene-1-carboxylic acid that is substituted by a methylenedioxy group at the 3,4 positions, by a methoxy group at position 8, and by a nitro group at position 10. It is the most abundant of the aristolochic acids and is found in almost all Aristolochia (birthworts or pipevines) species. It has been tried in a number of treatments for inflammatory disorders, mainly in Chinese and folk medicine. However, there is concern over their use as aristolochic acid is both carcinogenic and nephrotoxic.

Hypokalemic Periodic Paralysis: An autosomal dominant familial disorder characterized by recurrent episodes of skeletal muscle weakness associated with falls in serum potassium levels. The condition usually presents in the first or second decade of life with attacks of trunk and leg paresis during sleep or shortly after awakening. Symptoms may persist for hours to days and generally are precipitated by exercise or a meal high in carbohydrates. (Adams et al., Principles of Neurology, 6th ed, p1483)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tsai, CS1
Chen, YC1
Chen, HH1
Cheng, CJ1
Lin, SH1

Other Studies

1 other study available for aristolochic acid i and Hypokalemic Periodic Paralysis

ArticleYear
An unusual cause of hypokalemic paralysis: aristolochic acid nephropathy with Fanconi syndrome.
    The American journal of the medical sciences, 2005, Volume: 330, Issue:3

    Topics: Adult; Aristolochic Acids; Fanconi Syndrome; Humans; Hypokalemic Periodic Paralysis; Male; Medicine,

2005